Merck adds to Bovilis range with approved intranasal coronavirus vaccine
Merck Animal Health has extended its Bovilis vaccine range by gaining the first USDA authorization for a modified-live vaccine to aid the reduction of enteric disease caused by bovine coronavirus (BCV).